ABSTRACT Vitamin A administration in children reduces the incidence of severe diarrhea during the subsequent few months. We therefore examined the effect of treatment with vitamin A during acute diarrhea on the episode duration and severity. In a double-blind controlled field trial, 900 children 1 to 5 y of age with acute diarrhea of°7 d duration were randomly assigned to receive vitamin A (60 mg) or a placebo. Children were followed up at home every alternate day until they recovered from the diarrheal episode. In all study children, those treated with vitamin A had a significantly lower risk of persistent diarrhea [odds ratio (OR) 0.30, 95% confidence interval (CI) 0.07-0.97], but there was no effect on the mean diarrheal duration or the mean stool frequency. In the subgroup of children who were not breast-fed, the mean diarrheal duration [ratio of geometric means (GM) 0.84, 95% CI 0.72-0.97], mean number of stools passed after the intervention (ratio of GM 0.73, 95% CI 0.56-0.95), the proportion of episodes lasting ¢14 d (P Å 0.002) and the percentage of children who passed watery stools on any study day (OR 0.40, 95% CI 0.21-0.77) were significantly lower in those treated with vitamin A. We conclude that administration of vitamin A during acute diarrhea may reduce the severity of the episode and the risk of persistent diarrhea in non-breast-fed children. Similar benefit was not seen in breast-fed children.
acute diarrhea and to reduce the risk of episode persistence The current management of acute diarrhea is based on oral are therefore needed. rehydration salts (ORS) solution for prevention and treatment Further, vitamin A deficiency has been found to be associof dehydration, continued feeding, and antibiotics only for the ated with increased diarrheal morbidity (Shahid et al. 1988 ). treatment of cholera and dysentery. Standard ORS solution A significant reduction in the incidence of severe diarrhea was does not reduce the average duration or severity of acute wareported in children given 60 mg of vitamin A at 4-mo intertery diarrhea or the risk of episode persistence.
vals (Barreto et al. 1994 ). Vitamin A is absorbed in sufficient Nearly 20% of diarrheal episodes last longer than 1 wk amounts during acute diarrhea (Reddy et al. 1986 ). It is there- (Sazawal et al. 1995) and 10% longer than 2 wk (Bhan et al. fore of interest to determine whether these effects of vitamin 1989). When children revisit physicians because diarrhea has A treatment appear early enough following administration to not ceased within 5-7 d, the latter often prescribe ineffective be of significant benefit in the treatment of acute diarrhea. and potentially harmful anti-diarrheal drugs. In addition,
We hypothesized that treatment with 60 mg of vitamin A mothers, often on the advice of physicians, change the freduring acute diarrhea reduces the average duration and severity quency, amount and consistency of foods offered to the child, of the treated episode and the risk of its persistence. This issue which severely curtails dietary intake. The subsequent lack of was examined in a randomized placebo-controlled field trial. nutrients may convert marginal into severe malnutrition, delay intestinal epithelial recovery and further increase the duration and severity of diarrhea and malabsorption. The subset of per-MATERIALS AND METHODS sistent diarrhea episodes, although smaller in number than
The study was conducted in the urban slum of Govindpuri in acute diarrhea, accounts for 23 to 62% of diarrhea-associated New Delhi, which has about 30,000 inhabitants. Vitamin A prodeaths in developing countries . Treatment apphylaxis had not been routinely given in this area during the preproaches to decrease the average duration and stool output in ceding 3 y.
Children attending the solitary government health facility in the area with diarrheal duration of°7 d were considered for inclusion Analysis. Out of the 900 children enrolled, five did not complete the study because consent was withdrawn at the first post-enrollment 1.0% in those aged 23 mo or less, 5.3% in those 24-36 mo of age and 3.2% in children older than 36 mo.
visit; these children were excluded from the final analysis. Student's t test (two-tailed) was used for comparisons of continuAfter informed consent was obtained, the child was examined by a physician. Details were sought on the socio-economic status of the ous variables between groups; those with skewed distribution were normalized by log transformation, and a two-tailed t test was applied family, features of the current illness and feeding practices.
The study was approved by the institutional and World Health to the transformed data. A paired t test was used to compare preand post-intervention serum retinol concentrations. The confidence Organization (WHO) ethics committees.
Randomization. The enrolled children were randomized to reintervals (CI) for means and difference in means were calculated (Gardner and Altman 1989) . Categorical variables were compared ceive 60 mg of vitamin A or a placebo. The randomization code was drawn up by the WHO using a simple randomization scheme. The using the chi square or Fisher exact test (Armitage and Berry 1987) . Episodes that lasted for 14 or more days post-enrollment were vitamin A and placebo capsules supplied by the WHO were labeled serially; each child was administered the contents of the capsule next classified as persistent. in serial number, by a physician at enrollment. A replacement capsule was available for each child, to be given in the event that the contents
RESULTS
of the main capsule were vomited within 30 min of administration.
There were no significant differences in the age, parental Sample size estimates. The study was designed to detect a 20% literacy rates, nutritional status, feeding patterns or pre-enrolldifference in the post-intervention diarrheal duration between the ment illness characteristics between the treatment groups (Tatreatment groups. The mean [3.6 d (SD 3.2)] diarrheal duration used for these calculations was based on an earlier investigation in similar ble 1). Only one child (vitamin A group) had signs of dehydrapatients (M. K. Bhan, unpublished data). We estimated that 438 tion at enrollment. the change in serum retinol concentration between baseline At each visit mothers were asked about the frequency and characand 1 mo after supplementation across the two treatment teristics of stools, fever, vomiting, cough and other related symptoms, and visits to health care providers. Weights to the nearest 100 g and groups did not show significant differences (P Å 0.13). Furtherheights (lengths) to the nearest 0.1 cm were measured at enrollment more, the mean serum retinol concentrations 1 mo after sup- In the analysis on all children aged 1-5 y, the risk of level of P õ 0.20, with the exception of sex and pre-enrollment diarrheal duration. persistent diarrhea was significantly reduced in the vitamin A-treated children (OR 0.30, 95% CI 0.07-0.97). However, The beneficial effect of vitamin A, after adjustment, remained significant for both mean diarrheal duration (P Å 0.03) the mean diarrheal duration, number of diarrheal stools passed during the episode and the weight changes during the study and mean number of stools during the episode (P Å 0.02). A high pre-enrollment 24-h stool frequency was also indepenwere similar in the two groups ( Table 2) .
Undernourished children and those that were not breastdently associated with an increase in the mean number of stools passed after supplementation (P Å 0.03). No other cofed may be expected to have a higher prevalence of severe subclinical vitamin A deficiency, so vitamin A may have a variates were significantly associated with either of the outcome variables. greater impact in these subgroups. A standard test of interaction (Pocock 1983 ) suggested a significant interaction between breast-feeding status and effect of vitamin A supplementation on the mean diarrheal duration (P Å 0.01), whereas there was DISCUSSION no such interaction for weight-for-height status categorized as°8 0% and ú80% of NCHS median (P Å 0.60). The children In this study, vitamin A-treated children had a reduced risk of persistence of diarrheal episode, but no significant benefit in who received any breast-feeding in the 24-h period prior to enrollment were categorized as breast-fed.
other primary outcomes. Because of the significant interaction between breast-feedIn a secondary analysis, we therefore compared the outcomes in children supplemented with vitamin A or placebo ing status and vitamin A effect on acute diarrhea, we analyzed results by breast-feeding status. This showed that the effect of within the subgroups of breast-fed and non-breast-fed children. Among the non-breast-fed children, there was a significant vitamin A treatment on acute diarrhea depends on breastfeeding status; vitamin A treatment significantly improves the reduction in all the main study outcomes in the vitamin Atreated episodes: 16% in the average diarrheal duration, 27% outcome of the treated diarrheal episodes in the non-breastfed children, whereas there was no significant effect in those in the mean stool frequency, and 60% in the proportion of children who passed watery stools. Eight (3.6%) episodes in who were breast-fed. In the non-breast-fed children, there was a significant reduction in all the primary outcomes, including the placebo and none in the vitamin A group became persistent (Table 3) . Among the breast-fed children, there were no stool frequency, days when watery stools were passed and the risk of persistent diarrhea. significant differences in any of these outcomes between the two groups.
These findings are consistent with reports that breast-feeding beyond the first year of life is protective against severe The mean diarrheal stool frequency segregated by study day in the non-breast-fed children is shown in Figure 1 . Compared vitamin A deficiency (Cohen et al. 1983 , Mahalanabis 1991 , Stanton et al. 1986 , Tarwatjo et al. 1982 , West et al. 1986 ). with the placebo group, the vitamin A-treated non-breastfed children had a 11% reduction in stool frequency on d 1
The mechanisms underlying the observed effect may be that the correction of subclinical vitamin A deficiency results in a (P Å 0.12), 20% on d 2 (P Å 0.03), 16% (P Å 0.16) on d 3 and 27% on d 7 (P Å 0.01).
rapid and effective repair of the intestinal epithelium following an acute enteric infection, because of the role of vitamin A To confirm that the favorable effect of vitamin A in nonbreast-fed children was not the result of confounding, we perin regulating cell division (Semba 1994) or enhancing immune response. Vitamin A has been shown to potentiate the antiformed a multiple linear regression analysis restricted to this subgroup. In this analysis, the outcome variable was diarrheal body response to a variety of antigens, including rotavirus, E. coli and cholera toxin (Ahmed et al. 1991, Friedman et al. duration on a log scale (model 1) and the mean number of stools on a log scale (model 2). The explanatory variables were 1991, Wiederman et al. 1993) as well as T cell function (Coutsoudis et al. 1992 , Semba 1994 . treatment group (placebo or vitamin A), age category (°23 or ú23 mo), sex (male/female), weight-for-height°80% of Furthermore, among several recent studies in Brazil, India, Haiti and Ghana that examined the effect of routine large-NCHS median (no/yes), pre-enrollment duration of diarrhea (°3 or ú3 d), blood in stools (no/yes), stool frequency in the dose vitamin A supplementation on subsequent diarrheal morbidity, a convincing reduction in diarrheal morbidity was 24 h before enrollment (°median/úmedian), and consumption of ORS before enrollment (no/yes). All the variables shown only in the Brazilian study (Barreto et al. 1994 , Bhandari et al. 1994 , Ghana VAST Study Team 1993 of the enrolled subjects were breast-fed, compared with 47.8% duration of diarrhea was 5.6 d in the treated children and 8.5 d in the controls. in the Indian study and 58% in the Haitian study.
The observed reduction in the risk of persistent diarrhea is Some limitations of the study need to be emphasized. First, for ethical reasons, all the children were given ORS packets extremely important because the risks of growth faltering and a fatal outcome are high with this disorder. Reduction in the and parents instructed on their use, making it difficult to assess the effect on the risk of developing dehydration. The 27% risk of developing persistent diarrhea may be one of the ways by which vitamin A decreases childhood mortality. The relareduction in the mean stool frequency and the fact that vitamin A-treated children were 60% less likely to have watery tively low rates of persistent diarrhea in this study compared with earlier studies at the same site may be due to early treatdiarrhea suggest that vitamin A may reduce stool output and the risk of dehydration in non-breast-fed children. Second, ment of dysentery and standard case management of diarrhea. Furthermore, the enrolled children could have been suffering the most significant findings of the study are based on subgroup analysis and need to be confirmed by others. from diarrhea for 7 d prior to the intervention, leading to an underestimate of persistent diarrhea.
The effect of vitamin A, although restricted only to the non-breast-fed children, is important because in many develThe only other trial in which the therapeutic efficacy of vitamin A (60 mg) for acute non-cholera watery diarrhea was oping countries breast-feeding is practiced only during the initial few months, and in other countries breast-feeding rates examined showed no effect of such treatment on stool output or average diarrheal duration (Henning et al. 1992 ). However, decline by the end of the first year (Popkin et al. 1982 , WHO 1981 . In addition, the majority of episodes of severe persistent it is noteworthy that in this study 89% of patients were breastfed and the sample size of 83 children was sufficient to detect diarrhea occur in children who are not breast-fed (WHO 1988) . only a 55% difference in the mean stool output between the two groups.
In conclusion, vitamin A treatment during acute diarrhea substantially reduced the episode severity, including the risk On the other hand, vitamin A administration during acute measles has been shown to reduce the risk of diarrhea and its of its persistence, in non-breast-fed children. A similar effect was not observed in breast-fed children. These results need to severity (Hussey and Klein 1990, Ogaro et al. 1993 ). In the study by Hussey and Klein (1990) , children with measles had be confirmed in other studies. a significant reduction in complications including pneumonia and diarrhea following vitamin A supplementation; the mean ACKNOWLEDGMENTS We wish to express our thanks to Jose Martines and Sheila Gore for their useful suggestions on the manuscript. We thank Kiran Bhatia for assistance in data analysis and the volunteer organization Action for Securing Health for All for support in the field.
